MedPath

Eulexin

EULEXINTM (flutamide) CAPSULES USP

Approved
Approval ID

56b6ba36-9b49-4422-a2a4-7bfa0d941a5d

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 13, 2022

Manufacturers
FDA

Waylis Therapeutics LLC

DUNS: 117678921

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Flutamide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code80725-600
Application NumberANDA075298
Product Classification
M
Marketing Category
C73584
G
Generic Name
Flutamide
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 13, 2022
FDA Product Classification

INGREDIENTS (1)

FLUTAMIDEActive
Quantity: 125 mg in 1 1
Code: 76W6J0943E
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Eulexin - FDA Drug Approval Details